Contemporary Role of Cardiac Magnetic Resonance in the Management of Patients with Suspected or Known Coronary Artery Disease

Abstract

Cardiac magnetic resonance imaging (CMR) is a useful non-invasive radiation-free imaging modality for the management of patients with coronary artery disease (CAD). CMR cine imaging provides the “gold standard” assessment of ventricular function, late gadolinium enhancement (LGE) provides useful data for the diagnosis and extent of myocardial scar and viability, while stress imaging is an established technique for the detection of myocardial perfusion defects indicating ischemia. Beyond its role in the diagnosis of CAD, CMR allows accurate risk stratification of patients with established CAD. This review aims to summarize the data regarding the role of CMR in the contemporary management of patients with suspected or known coronary artery disease.

Multimodality imaging for cardiotoxicity: state of the art and future perspectives

“…CMR, and especially stress CMR, has a significant role for the detection of acute and chronic ischemia, 79 providing an assessment of myocardial viability by LGE imaging, functional perfusion abnormalities using stress first-pass perfusion imaging, alongside the gold standard measurement of ventricular function. 80,81 Importantly, thanks to its unique ability for tissue characterization, it is able to investigate and diagnose coronary mimics, such as myocarditis or takotsubo cardiomyopathy-both relatively common causes of acute cardiotoxic events.…”

Role of feature tracking cardiac magnetic resonance imaging in early detection of cardiac dysfunction in β‐thalassemia patients recovered from COVID‐19: A cross‐sectional study

“…β‐Thalassemia major as a TDT and β‐thalassemia intermedia as a NTDT can cause iron overload due to regular transfusion and increased intestinal absorption, respectively 17 . Both groups of patients may suffer from cardiac complications due to iron overload 18,19 . Therefore, a close cardiovascular surveillance is reasonable, particularly in β‐thalassemia patients with increased baseline risk.…”

“… 17 Both groups of patients may suffer from cardiac complications due to iron overload. 18 , 19 Therefore, a close cardiovascular surveillance is reasonable, particularly in β‐thalassemia patients with increased baseline risk. This baseline risk can be previous cardiovascular comorbidities such as myocardial T2* <20 ms (ms), a personal history of previous or current impaired left ventricular function or a serum ferritin level >2000 ng/mL.…”